Results 161 to 170 of about 687,888 (183)
Some of the next articles are maybe not open access.
Medical Clinics of North America, 2001
To provide the most effective care for this difficult patient population, it is helpful to remember that patients with schizophrenia have disease-intrinsic limitations that limit their ability to participate in their care. These limitations are symptoms of a disease and not volitional.
D C, Goff, S, Heckers, O, Freudenreich
openaire +2 more sources
To provide the most effective care for this difficult patient population, it is helpful to remember that patients with schizophrenia have disease-intrinsic limitations that limit their ability to participate in their care. These limitations are symptoms of a disease and not volitional.
D C, Goff, S, Heckers, O, Freudenreich
openaire +2 more sources
Perspectives on Psychological Science, 2008
Theoretical conceptualizations of schizophrenia have undergone significant change in the past century. Through the application of behavioral science methodology, psychologists have played a major role in the pivotal scientific advances that have led us to contemporary models.
Elaine, Walker, Kevin, Tessner
openaire +2 more sources
Theoretical conceptualizations of schizophrenia have undergone significant change in the past century. Through the application of behavioral science methodology, psychologists have played a major role in the pivotal scientific advances that have led us to contemporary models.
Elaine, Walker, Kevin, Tessner
openaire +2 more sources
The Lancet, 2009
Schizophrenia is still one of the most mysterious and costliest mental disorders in terms of human suffering and societal expenditure. Here, we focus on the key developments in biology, epidemiology, and pharmacology of schizophrenia and provide a syndromal framework in which these aspects can be understood together.
Jim, van Os, Shitij, Kapur
openaire +4 more sources
Schizophrenia is still one of the most mysterious and costliest mental disorders in terms of human suffering and societal expenditure. Here, we focus on the key developments in biology, epidemiology, and pharmacology of schizophrenia and provide a syndromal framework in which these aspects can be understood together.
Jim, van Os, Shitij, Kapur
openaire +4 more sources
Psychiatric Clinics of North America, 1993
The pharmacologic treatment of the schizophrenic patient has remained substantively unchanged during the last 35 years. It is evident that as our knowledge of neuropharmacology has grown--the notion of schizophrenia being merely caused by a hyperdopaminergic state may be too simplistic.
S R, Marder +3 more
openaire +2 more sources
The pharmacologic treatment of the schizophrenic patient has remained substantively unchanged during the last 35 years. It is evident that as our knowledge of neuropharmacology has grown--the notion of schizophrenia being merely caused by a hyperdopaminergic state may be too simplistic.
S R, Marder +3 more
openaire +2 more sources